image credit- shutterstock
H.U. Group Holdings Inc., and its wholly owned subsidiary, Fujirebio Holdings, Inc. has announced that Fujirebio Diagnostics, Inc., a subsidiary of Fujirebio, has acquired all shares of Plasma Services Group, Inc. The transaction value has not been disclosed.
Plasma Services Group (PSG) has specialised in the collection, screening and supply of high quality and rare biological materials required for R&D and manufacturing in the in vitro diagnostics (IVD) and life science industries.
The company is particularly well positioned in the field of rare diseases. From its state-of-the-art FDA registered, ISO certified facility in Moorestown, NJ, USA, Plasma Services Group provides sera and other samples for materials of control reagents and calibrators for a wide range of diseases and offers sample collection services globally.
Goki Ishikawa, President & CEO of Fujirebio Holdings, Inc. said, “Current and future IVD and life science partners of Fujirebio and Plasma Services Group will benefit from the synergies in our combined offer of rare samples and biological materials, which in turn further reinforce Fujirebio’s position in the market as a trusted CDMO partner.”
“For over 20 years our mission at PSG has always been rooted in serving our customers with care, integrity, and a commitment to quality,” said Nichelle Fernandez, President of Plasma Services Group. “This next chapter with Fujirebio is deeply meaningful. It allows us to stay true to who we are while preserving the personal, responsive service our customers value. Together, we’re positioned to offer even stronger support for the scientists and innovators who rely on us. Our shared commitment to consistency will have a lasting impact across the global IVD landscape."
